Daewoong Pharmaceutical Sues Former Employees Who Moved to Medytox for "Spreading False Information"
[Asia Economy Reporter Cho Hyun-ui] Daewoong Pharmaceutical announced on the 2nd that it has filed a lawsuit for damages due to the spread of false information against former employee Yoo Mo, who moved to Medytox, at the Seoul Southern District Court.
Daewoong Pharmaceutical stated, "Mr. Yoo made false claims that 'a former employee of the competitor Medytox stole botulinum strains and production technology data and delivered them to Daewoong Pharmaceutical,' which is not true."
They added, "Mr. Yoo also lied that 'Daewoong Pharmaceutical arranged and fully paid for his study abroad in the United States as compensation.' Medytox has filed civil and criminal lawsuits against Daewoong Pharmaceutical based on these false claims and also filed a complaint with the U.S. International Trade Commission (ITC)."
Daewoong Pharmaceutical claimed, "Medytox has pursued a slanderous strategy that Daewoong Pharmaceutical conducted business using stolen strains and technology," and "as part of this, they promoted and hired Daewoong Pharmaceutical employees to lead the spread of false information."
Medytox and Daewoong Pharmaceutical have been engaged in a truth dispute for over four years regarding the source of the botulinum strains used as raw materials for botulinum toxin products known as 'Botox.' Medytox claims that Daewoong Pharmaceutical plagiarized its botulinum strains, while Daewoong Pharmaceutical insists that their strains are different from Medytox’s, maintaining a strong stance.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Medytox filed a complaint against Daewoong Pharmaceutical with the U.S. International Trade Commission (ITC). The ITC will issue a preliminary ruling on the 6th (local time). Daewoong Pharmaceutical raised its voice, saying, "If all the materials submitted to the ITC lawsuit are disclosed and verified, it will be clear who is lying," and "It is Medytox’s strains that were stolen."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
